Funding for this research was provided by:
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (-)
Received: 24 January 2020
Accepted: 7 April 2020
First Online: 21 April 2020
Ethics approval and consent to participate
: The study was approved by the Social Insurance Institution of Finland (Kela), from where the medication data were extracted and by the hospital, from where the clinical data were extracted. According to Finnish and EU legislation, consent from the patients or from the Ethical Board was not required because this was a retrospective register study.
: Not applicable.
: EJ, TM, and AH have received payments for lectures not related to this manuscript from pharmaceutical and other medical companies. The authors PP and TR declare that they have no competing interests.